Biocon, Asia’s premier biotechnology company, has been ranked by ‘Science’ Magazine at No. 6 on the annual Global ‘Top Twenty Employers’ list for the Bio-Pharma sector, a significant jump from No. 19 in 2012. According to the 2013 Top Biotech and Pharma Employers survey, the three Key Attributes associated with Biocon are socially responsible, clear vision and quality research.
For the second year in a row, Biocon is the only Asian Company to be a part of the Top 20 Elite List, which includes leading global innovator companies. This global ranking reflects the growing power of brand BIOCON, which is ably supported by its valuable partners, customers, employees and all other stakeholders.
Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: